Manjiree Karandikar, MD

TitleAssistant Professor
InstitutionUniversity of California San Francisco
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Keck Graduate Institute, Claremont, CAMBS05/2007Biopharmaceutical Drug Discovery and Development
    Wayne State University School of Medicine , Detroit, MIMD05/2012Medicine
    Harbor UCLA Medical Center, Torrance, CAResidency06/2015Pediatrics
    Clinical / Translational Research Academy, Harvard Catalyst, Boston, MACertificate05/2018Advanced Training in Clinical and Translational Research
    Boston Children's Hospital, Boston, MAFellowship06/2018Pediatric Infectious Disease

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Dixit A, Karandikar MV, Jones S, Nakamura MM. Safety and Tolerability of Moxifloxacin in Children. J Pediatric Infect Dis Soc. 2018 Jun 25. PMID: 29939314.
      View in: PubMed
    2. Chiotos K, Tamma PD, Flett KB, Naumann M, Karandikar MV, Bilker WB, Zaoutis T, Han JH. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children. Antimicrob Agents Chemother. 2017 Dec; 61(12). PMID: 28971864.
      View in: PubMed
    3. Olszewski AE, Karandikar MV, Surana NK. Aeromonas as a Cause of Purulent Folliculitis: A Case Report and Review of the Literature. J Pediatric Infect Dis Soc. 2017 Mar 01; 6(1):e1-e3. PMID: 27988495.
      View in: PubMed
    Manjiree's Networks
    Derived automatically from this person's publications.
    Related Authors
    People who share related concepts with this person.